X4 Pharmaceuticals secures $150M loan
- Loan of up to $150M with K2 HealthVentures
- First tranche of $80M used to repay existing loan
- Second tranche of $70M available upon request
XFOR
X4 Pharmaceuticals, Inc SEC filings
Every EDGAR filing for X4 Pharmaceuticals, Inc (XFOR), newest first, with AI summaries and stories.
- Ticker
- XFOR
- CIK
- 1501697
- Sector
- Biotech and pharma
- Latest filing
- Oct 8
Next: 10-Q expected ~Nov 6 (deadline Nov 16) · earnings expected ~Nov 9
Insider activity
No open-market insider buys in the last 30 days.
Also: 1 open-market sale ($34K).
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KX4 Pharmaceuticals, IncXFORLIVE ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE X4 PHARMACEUTICALS INC 4.6% held by FMR LLC
- FMR LLC owns 4,558,616 shares
- 4.6% of total shares
- Abigail P. Johnson also owns 4,558,616 shares
FMR LLC, filed by
ROUTINE4X4 Pharmaceuticals, IncXFORLIVE KIRSKE DAVID sells shares
- 10/01/2026 sale of 11,767 shares
- Price range $2.82 to $2.92
- 64,418 restricted stock units reported
David Kirske
ROUTINE144X4 Pharmaceuticals, IncXFORLIVE David Kirske, planned sale of XFOR shares
David Kirske
ROUTINESCHEDULE 13GX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by Venrock Healthcare Capital Partners III, L.P.
Venrock Healthcare Capital Partners III, L.P., filed by
ROUTINE8-KX4 Pharmaceuticals, IncXFORLIVE ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
PERCEPTIVE ADVISORS LLC, filed by
ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by Deep Track Capital, LP (amended)
Deep Track Capital, LP, filed by
ROUTINE4X4 Pharmaceuticals, IncXFORLIVE 2 insider filings
John Volpone, insider filing for XFOR
Show all 2
- 4Insider filing for XFOR
- 4Insider filing for XFOR
John Volpone, reporting
ROUTINE144X4 Pharmaceuticals, IncXFORLIVE 2 Form 144 notices
John Volpone, planned sale of XFOR shares
Show all 2
- 144Planned insider sale of XFOR shares
- 144Planned insider sale of XFOR shares
John Volpone, reporting
NOTABLE10-QX4 Pharmaceuticals, IncXFORLIVE ROUTINESCHEDULE 13GX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by BlackRock, Inc.
BlackRock, Inc., filed by
ROUTINE4X4 Pharmaceuticals, IncXFORLIVE 3 insider filings
David Kirske, insider filing for XFOR
Show all 3
- 4Insider filing for XFOR
- 3New insider at XFOR
- 4Insider filing for XFOR
David Kirske, reporting
ROUTINE8-KX4 Pharmaceuticals, IncXFORLIVE ROUTINEEFFECTX4 Pharmaceuticals, IncXFORLIVE ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
PERCEPTIVE ADVISORS LLC, filed by
ROUTINE8-K/AX4 Pharmaceuticals, IncXFORLIVE ROUTINE4X4 Pharmaceuticals, IncXFORLIVE David Kirske, insider filing for XFOR
David Kirske, reporting
ROUTINE144X4 Pharmaceuticals, IncXFORLIVE David Kirske, planned sale of XFOR shares
David Kirske, reporting
ROUTINE8-KX4 Pharmaceuticals, IncXFORLIVE ROUTINES-3X4 Pharmaceuticals, IncXFORLIVE NOTABLE10-QX4 Pharmaceuticals, IncXFORLIVE ROUTINEARSX4 Pharmaceuticals, IncXFORLIVE ROUTINEDEFA14AX4 Pharmaceuticals, IncXFORLIVE ROUTINEDEF 14AX4 Pharmaceuticals, IncXFORLIVE NOTABLE10-KX4 Pharmaceuticals, IncXFORLIVE ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by Stanley Morgan (amended)
Stanley Morgan, filed by
ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE 3 13G filings
Ownership stake disclosure by Trails Edge Capital Partners, LP (amended)
Show all 3
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
- SCHEDULE 13G/AOwnership stake disclosure (amended)
Trails Edge Capital Partners, LP, filed by
ROUTINESCHEDULE 13GX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by Saturn V Capital Management LP
Saturn V Capital Management LP, filed by
ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by Nantahala Capital Management, LLC (amended)
Nantahala Capital Management, LLC, filed by
ROUTINESCHEDULE 13GX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by Stanley Morgan
Stanley Morgan, filed by
ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by FMR LLC (amended)
FMR LLC, filed by
ROUTINESCHEDULE 13G/AX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by Empery Asset Management, LP (amended)
Empery Asset Management, LP, filed by
ROUTINE4X4 Pharmaceuticals, IncXFORLIVE Gary Bridger, insider filing for XFOR
Gary Bridger, reporting
ROUTINE4X4 Pharmaceuticals, IncXFORLIVE 3 insider filings
Craecker Francoise de, insider filing for XFOR
Show all 3
- 4Insider filing for XFOR
- 4Insider filing for XFOR
- 4Insider filing for XFOR
Craecker Francoise de, reporting
ROUTINESCHEDULE 13GX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by Nantahala Capital Management, LLC
Nantahala Capital Management, LLC, filed by
ROUTINESCHEDULE 13GX4 Pharmaceuticals, IncXFORLIVE Ownership stake disclosure by FMR LLC
FMR LLC, filed by
NOTABLE10-QX4 Pharmaceuticals, IncXFORLIVE ROUTINE8-KX4 Pharmaceuticals, IncXFORLIVE ROUTINESCHEDULE 13GX4 Pharmaceuticals, IncLIVE Ownership stake disclosure by PERCEPTIVE ADVISORS LLC
PERCEPTIVE ADVISORS LLC, filed by
ROUTINE4X4 Pharmaceuticals, IncLIVE 2 insider filings
Adam R Craig, insider filing for X4 Pharmaceuticals, Inc
Show all 2
- 4Insider filing for X4 Pharmaceuticals, Inc
- 4Insider filing for X4 Pharmaceuticals, Inc
Adam R Craig, reporting